Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Pilot Study of Bevacizumab in Combination with Docetaxel and Cyclophosphamide As Adjuvant Treatment for Patients with Early Stage HER-2 Negative Breast Cancer, Including Analysis of Candidate Circulating Markers of Cardiac Toxicity: ICORG 08–10 Trial

Giuseppe Gullo,Alex J. Eustace,Alexandra Canonici,Denis M. Collins, Michael J. Kennedy,Liam Grogan,Oscar Breathhnach,John McCaffrey,Maccon Keane,Michael J. Martin,Rajnish Gupta,Gregory Leonard,Miriam O'Connor,Paula M. Calvert,Paul Donnellan,Janice Walshe,Enda McDermott,Kathleen Scott,Andres Hernando,Imelda Parker,David W. Murray,Alice C. O'Farrell,Ashwini Maratha,Patrick Dicker,Mairin Rafferty,Verena Murphy,Norma O'Donovan,William M. Gallagher,Bonnie Ky,Dimitrios Tryfonopoulos,Brian Moulton,Annette T. Byrne,John Crown

Therapeutic Advances in Medical Oncology（2019）

Cited 11|Views96
Key words
bevacizumab,breast cancer,cardiotoxicity biomarker,docetaxel,cyclophosphamide
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined